At a glance
- Originator Bristol-Myers Squibb
- Class Anxiolytics
- Mechanism of Action Corticotropin releasing hormone inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Anxiety disorders
Most Recent Events
- 24 Aug 2001 No-Development-Reported for Anxiety disorders in USA (Unknown route)
- 03 Sep 1998 New profile
- 03 Sep 1998 Preclinical development for Anxiety disorders in USA (Unknown route)